98 related articles for article (PubMed ID: 1672381)
21. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
22. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
Ocaña M; Barrios M; Baeyens JM
J Pharmacol Exp Ther; 1996 Mar; 276(3):1136-42. PubMed ID: 8786544
[TBL] [Abstract][Full Text] [Related]
23. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
24. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126
[TBL] [Abstract][Full Text] [Related]
25. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
Vaupel DB; Cone EJ; Johnson RE; Su TP
J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
[TBL] [Abstract][Full Text] [Related]
26. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
Gistrak MA; Paul D; Hahn EF; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
29. Kappa opioid analgesia is dependent on serotonergic mechanisms.
Vonvoigtlander PF; Lewis RA; Neff GL
J Pharmacol Exp Ther; 1984 Nov; 231(2):270-4. PubMed ID: 6092612
[TBL] [Abstract][Full Text] [Related]
30. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
Testa R; Guarneri L; Poggesi E; Angelico P; Velasco C; Ibba M; Cilia A; Motta G; Riva C; Leonardi A
J Pharmacol Exp Ther; 1999 Sep; 290(3):1258-69. PubMed ID: 10454502
[TBL] [Abstract][Full Text] [Related]
31. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.
Bardin L; Colpaert FC
Eur J Pain; 2004 Jun; 8(3):253-61. PubMed ID: 15109976
[TBL] [Abstract][Full Text] [Related]
32. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
Schmauss C; Yaksh TL
J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
[TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
34. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
35. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
Paul D; Pick CG; Tive LA; Pasternak GW
J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
[TBL] [Abstract][Full Text] [Related]
37. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
38. Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice.
Millan MJ
Pain; 1994 Jul; 58(1):45-61. PubMed ID: 7970839
[TBL] [Abstract][Full Text] [Related]
39. Evidence that mu-opioid receptors mediate midbrain "stimulation-produced analgesia" in the freely moving rat.
Millan MJ; Członkowski A; Herz A
Neuroscience; 1987 Sep; 22(3):885-96. PubMed ID: 2825072
[TBL] [Abstract][Full Text] [Related]
40. Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia.
Nemmani KV; Mogil JS
Neuropharmacology; 2003 Mar; 44(3):304-10. PubMed ID: 12604090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
